Lamisil 1% cream

Land: Storbritannien

Sprog: engelsk

Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiv bestanddel:

Terbinafine hydrochloride

Tilgængelig fra:

Necessity Supplies Ltd

ATC-kode:

D01AE15

INN (International Name):

Terbinafine hydrochloride

Dosering:

10mg/1gram

Lægemiddelform:

Cutaneous cream

Indgivelsesvej:

Cutaneous

Klasse:

No Controlled Drug Status

Recept type:

Valid as a prescribable product

Produkt oversigt:

BNF: 13100200

Produktets egenskaber

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Lamisil AT 1% Cream
Boots Athlete’s Foot 1%w/w Cream
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Terbinafine hydrochloride 1% w/w
3
PHARMACEUTICAL FORM
Cream
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
The treatment of tinea pedis (athlete’s foot) and tinea cruris
(dhobie itch/jock
itch) caused by _Trichophyton_ (e.g. _T. rubrum, T. mentagrophytes, T.
_
_verrucosum, T. violaceum) and Epidermophyton floccosum. _
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Adults and children over 16 years of age
Lamisil AT 1% Cream is applied once daily.
DURATION AND FREQUENCY OF TREATMENT
Duration of treatment is one week for tinea pedis and tinea cruris.
Relief of clinical
symptoms
usually
occurs
within
a
few
days.
Irregular
use
or
premature
discontinuation of treatment carries the risk of recurrence. If there
are no signs of
improvement after two weeks, the diagnosis should be verified by a
physician.
DOSING IN SPECIAL POPULATIONS:
Paediatric population
The experience with topical Lamisil AT 1% Cream in children is still
limited and its
use in children under 16 years cannot therefore be recommended.
Elderly patients
There is no evidence to suggest that elderly patients require
different dosages or
experience side-effects different to those of younger patients.
Method of administration
For cutaneous use.
The affected area should be cleaned and dried thoroughly before
application of
Lamisil AT 1% Cream. The cream should be applied to the affected skin
and
surrounding area in a thin layer and rubbed in lightly. In the case of
intertriginous
infections (interdigital, intergluteal, inguinal) the application may
be covered with a
gauze strip, especially at night.
4.3
CONTRAINDICATIONS
Hypersensitivity to terbinafine or to any of the excipients contained
in the
cream, listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Lamisil AT 1% cream is for external use only.
Should be used with caution in patients with lesions where alcohol
could be
irrita